Integrative genomic analyses reveal regional and cellular convergence between uterine fibroids and endometriosis

Two of the most common gynecological conditions affecting women are uterine fibroids and endometriosis. Fibroids are benign growths made of smooth muscle that develop within the wall of the uterus, often causing heavy bleeding and pain. Endometriosis occurs when tissue similar to the lining of the uterus grows outside the uterus, leading to chronic pain and infertility. While these conditions affect different parts of the reproductive system and look different under a microscope, they share a striking similarity: both are driven by estrogen and tend to run in families. For decades, scientists have known that a woman's genetic makeup influences her risk of developing either condition, and that the two often appear together in the same families. However, the precise nature of this genetic connection has remained a mystery. It was unclear whether the two diseases shared a broad, general genetic vulnerability, or if their risks were concentrated in specific, overlapping pockets of DNA. Understanding this distinction is crucial because it determines whether these conditions are essentially the same problem manifesting in different places, or if they are distinct diseases that happen to share a few common risk factors.

A team of researchers set out to solve this puzzle by examining the genetic blueprints of thousands of women. They analyzed data from a massive Finnish study that included information on over 31,000 women with fibroids and more than 15,000 with endometriosis. By comparing the DNA of these women against a vast reference library of human genetic variation, the scientists could measure how much the two conditions overlapped at the level of our genes. Their first major finding confirmed what many suspected but had never precisely measured: there is a moderate, positive genetic link between the two disorders. This means that the same set of common genetic variations contributes to the risk of both conditions, but the link is not absolute; the diseases are related, yet they are not identical twins.

To dig deeper, the researchers broke the genome down into thousands of small, independent regions to see where the overlap was strongest. They discovered that the shared genetic risk is not spread evenly across the entire genome. Instead, it is concentrated in sixteen specific regions. In these specific areas, the genetic signals for both diseases pointed in the same direction, suggesting that these pockets of DNA are critical hubs where the two conditions converge. Outside of these sixteen regions, the genetic architecture of the two diseases diverges significantly, with each condition having its own unique set of risk genes. This finding refutes the idea that the two diseases are driven by a single, uniform genetic mechanism. Instead, they appear to be a mix of shared vulnerabilities in specific locations and distinct, disease-specific factors elsewhere.

The study then turned its attention to the genes located within these sixteen shared regions. Using a method that groups genetic signals by the genes they affect, the researchers identified ten specific genes that were significantly associated with both fibroids and endometriosis. Seven of these ten genes were found within the sixteen high-risk regions identified earlier, creating a strong, convergent signal. These genes are involved in processes like hormone signaling and the development of reproductive tissues. Crucially, the researchers also found that while these ten genes are shared, the vast majority of the genes driving each disease are unique to that specific condition. There were 137 genes linked only to fibroids and 28 linked only to endometriosis, highlighting that while the diseases share a foundation, they are built upon very different structural supports.

To understand what these shared genes are actually doing inside the body, the team looked at how they behave in different types of cells. They analyzed data from single-cell studies, which allow scientists to see gene activity in individual cells rather than just in a mixture of tissue. This analysis revealed that the shared genetic risk is heavily concentrated in stromal cells. These are the connective tissue cells that provide the structural framework for organs and play a key role in how tissues respond to hormones. The findings suggest that the common thread between fibroids and endometriosis is a shared vulnerability in these hormone-responsive connective tissues. While fibroids are known for their smooth muscle content and endometriosis for its inflammatory nature, the genetic data points to the underlying stromal cells as the common ground where the risk for both conditions originates.

Finally, the researchers examined the specific DNA variations within these shared regions to see if a single genetic change could explain the risk for both diseases. They found that the picture is more complex. In several key areas, the genetic signal is not caused by one single mutation but by a cluster of multiple, closely linked variations. This allelic complexity means that the relationship between the two diseases cannot be reduced to a simple "one gene, two diseases" model. The genetic architecture is intricate, with different combinations of variants contributing to the risk in ways that are difficult to untangle without further study.

In summary, this research paints a nuanced picture of the relationship between uterine fibroids and endometriosis. They are not the same disease, nor are they entirely unrelated. They share a moderate genetic connection that is concentrated in specific regions of the genome and centered on the biology of hormone-responsive connective tissue. However, this shared susceptibility is accompanied by a large amount of unique genetic architecture that defines each condition separately. The study provides a clear map of where these two common disorders overlap and where they diverge, offering a foundation for future research to understand the specific biological mechanisms that drive each disease. By identifying the shared stromal context and the specific regions of convergence, scientists now have a more precise target for understanding how these conditions develop and how they might be treated in the future.